|
|
|
Revisiting China’s response to coronavirus disease 2019 |
Guangbiao Zhou1, Saijuan Chen2( ), Zongjiu Zhang3(), Zhu Chen2 |
1. State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
2. State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, National Research Center for Translational Medicine (Shanghai), Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
3. Institute for Hospital Management, Tsinghua University, Beijing 100084, China |
|
|
|
|
|
|
Corresponding Author(s):
Saijuan Chen,Zongjiu Zhang
|
|
Just Accepted Date: 23 January 2024
Online First Date: 29 January 2024
Issue Date: 06 February 2024
|
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
| |
Shared |
|
|
|
|
| |
Discussed |
|
|
|
|
